三七叶甙制备抗癌活性成分20(R)-人参皂甙-Rh2和人参皂甙Rg3

人参皂甙-Rh2(ginsenoside Rh2)和Rg3是从人参中分离得到的具有抗癌活性的四环三萜类原人参二醇型低糖链皂甙单体。其中,以人参皂甙为主要成分的抗癌新药Rg3参—胶囊已获国家药品监督管理局颁发的中药一类新药证书。皂甙类成分要从植物中分离困难。为了得到某些活性     

碱催化降解法制备抗癌活性化合物20(S)-原人参二醇

通过碱催化降解制备了与植物体内结构一致且具有抗癌活性的人参皂苷元--20(S)-原人参二醇,并对其进行分离及结构表征. 将西洋参茎叶总皂苷和强碱溶于高沸点有机溶剂中,在常压和高温条件下进行降解. 通过正交试验确定了制备20(S)-原人参二醇的最佳降解条件,并将降解物经萃取、 柱层析及重结晶等方法分离得到20(S)-原人参二醇. 按西洋参茎叶总皂苷计,20(S)-原人参二醇产率为5.01%,纯度为98.56% . 通过理化性质和光谱分析可确认该化合物为20(S)-原人参二醇. 所制备的20(S)-原人参二醇具有产率和纯度高及成本低等特点.     

Transformation of Ginsenosides Rg1 and Rb1, and Crude Sanchi Saponins by Human Intestinal Microflora

Fractions major in ginsenosides Rg₁ and Rb₁ from Sanchi saponins were transformed by human fecal flora. This study yielded the corresponding aglycone, protopanaxatriol, in 49.4% from Rg₁, protopanaxadiol 20‐O‐glucoside in 54.8% from Rb₁, and dihydroprotopanaxadiol 20‐O‐glucoside in 87.6% from dihydro Rb₁, by incubation with healthy feces for 70 h in subgram level. Never the less large‐scale incubation of crude Sanchi saponins revealed the complete biotransformation of Rb₁ and the almost unchanged Rg₁. A small amount of Rg₁ was found to be converted into 20 R‐ginsenoside Rh₁ and its dehydration product, 20(22) Z‐ginsenoside Rh₄.     

Biotransformation of the saponins in Panax notoginseng leaves mediated by gut microbiota from insomniac patients

Saponins extracted from Panax notoginseng leaves by methanol or water could be orally administrated for insomnia with very low bioavailability, which might be bio-converted by gut microbiota to generate potential bioactive products. Moreover, gut microbiota profiles from insomniac patients are very different from healthy subjects. We aimed to compare the metabolic characteristics and profiles of the two saponins extract by incubation with gut microbiota from insomniac patients. The ginsenosides, notoginsenosides, and metabolites were identified and relatively quantified by high-performance liquid chromatography-tandem mass spectrometry. Gut microbiota was profiled by 16S ribosomal RNA gene sequencing. The results showed that saponins were very different between methanol or water extract groups, which were metabolized by gut microbiota to generate similar yields. The main metabolites included ginsenoside Rd, ginsenoside F₂, ginsenoside C-Mc or ginsenoside C-Y, ginsenoside C-Mx, ginsenoside compound K, and protopanaxadiol in both groups, while gypenoside XVII, notoginsenoside Fe, ginsenoside Rd₂, and notoginsenoside Fd were the intermediates in the methanol group. Moreover, the microbial, Faecalibacterium prausnitzi, could bio-convert the saponins to obtain the corresponding metabolites. Our study implied that saponins extracted from P. notoginseng leaves by methanol or water could be used for insomniac patients due to gut microbiota biotransformation.     

Analysis of bioactive components and multi‐component pharmacokinetics of saponins from the leaves of Panax notoginseng in rat plasma after oral administration by LC–MS/MS

In this study, simple ultra‐high performance liquid chromatography coupled with quadrupole time‐of‐flight mass tandem mass spectrometry is used to characterize the absorbed components in rat plasma after the oral administration of saponins from the leaves of Panax notoginseng. Seventeen prototype compounds are structurally characterized. Furthermore, a simple and sensitive liquid chromatography with tandem mass spectrometry method is also used for the simultaneous determination of notoginsenoside Fc, ginsenoside Rb1, ginsenoside Rc, ginsenoside Rb3, ginsenoside Rd, and notoginsenoside Fe in rat plasma within 5 min. After n‐butanol mediated liquid–liquid extraction, all analytes were separated on a C₁₈ column and monitored in negative ion mode. Linearity, sensitivity, intra‐ and inter‐assay precision, accuracy, recovery, matrix effect, and stability were all within acceptable ranges. The validated liquid chromatography with tandem mass spectrometry method is successfully applied to the pharmacokinetic study of saponins from the leaves of Panax notoginseng in rats after oral administration. The results suggest that notoginsenoside Fc and ginsenoside Rb3 showed relatively higher exposure compared with other saponins. All saponins showed a long duration in plasma with a t_1/2 longer than 15 h, except notoginsenoside Fe (t_1/2 = 2.78 h). This study provides important information about the metabolism of saponins from the leaves of Panax notoginseng, which is useful for completely understanding its mechanism of action.     

Enzyme-linked immunosorbent assay for the determination of 20(S)-protopanaxatriol

A highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) method has been developed for the determination of 20(S)-protopanaxatriol (PPT), one of the major aglycones of dammarane-type ginseng saponins. Polyclonal antibodies raised against ginsenoside F₁ (GF₁)-bovine serum albumin showed high reactivities to PPT and GF₁, whereas they exhibited minor or even no cross-reactivities to other ginsenosides and protopanaxadiol (0.19%). The working range of this method extends from 50 pg ml⁻¹ to 20 ng ml⁻¹ of PPT. The assay reported here has been validated against an HPLC technique using PPT-containing samples and was shown to correlate closely (γ=0.993). This ELISA could be a useful tool for the determination of PPT contained in biological fluids and plant materials.     

Synthesis of (S)-Propranolol by Chemicoenzymatic Approach

(S)-Propranolol, [1-isopropylamino-3-(1-naphthoxy)-2-propanol], which possesses important β-adrenergic blocking activity, has been synthesized by a chemicoenzymatic approach. The 2S-absolute configuration was created by the enzyme-mediated asymmetric hydrolysis of the (±)-2-acetoxy-1-chloro-3-(1-naphthoxy)-2-naphthoxy)-2-propanol. The enzymatically produced chiral intermediate was then chemically converted to optically pure (S)-propranolol.     

Simultaneous determination of 20(S)‐protopanaxadiol and its three metabolites in rat plasma by LC–MS/MS: application to their pharmacokinetic studies

The aim of this study was to develop an LC–MS/MS method for simultaneous determination of 20(S) protopanaxadiol (PPD) and its three metabolites, PPD‐glucuronide (M1), (20S,24S)‐epoxy‐dammarane‐3,12,25‐triol (M2) and (20S,24R)‐epoxydammarane‐3,12,25‐triol (M3), in rat plasma. Precipitation with acetonitrile was employed for sample preparation and chromatographic separations were achieved on a C₁₈ column. The sample was detected using triple quadrupole tandem mass spectrometer with selected reaction monitoring mode. The monitored precursor‐to‐product ion transitions were m/z 459.4 → 375.3 for PPD, m/z 635.4 → 113.0 for M1, m/z 477.4 → 441.4 for M2 and M3 and m/z 475.4 → 391.3 for IS. The developed assay was validated according to the guidelines of the US Food and Drug Administration. The calibration curves showed good linearity over the tested concentration ranges (r > 0.9993), with the LLOQ being 1 ng/mL for all analytes. The intra‐ and inter‐day precisions (RSD) were < 9.51% while the accuracy (RE) ranged from −8.91 to 12.84%. The extraction recovery was >80% and no obvious matrix effect was detected. The analytes were stable in rat plasma with the RE ranging from −12.34 to 9.77%. The validated assay has been successfully applied to the pharmacokinetic study of PPD as well as its metabolites in rat plasma. According to the pharmacokinetic parameters, the in vivo exposures of M1, M2 and M3 were 11.91, 47.95 and 22.62% of that of PPD, respectively.     

Dose‐dependent exposure profile and metabolic characterization of notoginsenoside R1 in rat plasma by ultra‐fast liquid chromatography–electrospray ionization–tandem mass spectrometry

Notoginsenoside R₁ (NGR₁), a diagnostic protopanaxatriol‐type (ppt‐type) saponin in Panax notoginseng, possesses potent biological activities including antithrombotic, anti‐inflammatory, neuron protection and improvement of microcirculation, yet its pharmacokinetics and metabolic characterization as an individual compound remain unclear. The aim of this study was to investigate the exposure profile of NGR₁ in rats after oral and intravenous administration and to explore the metabolic characterization of NGR₁. A simple and sensitive ultra‐fast liquid chromatographic–tandem mass spectrometric method was developed and validated for the quantitative determination of NGR₁ and its major metabolites, and for characterization of its metabolic profile in rat plasma. The blood samples were precipitated with methanol, quantified in a negative multiple reaction monitoring mode and analyzed within 6.0 min. Validation parameters (linearity, precision and accuracy, recovery and matrix effect, stability) were within acceptable ranges. After oral administration, NGR₁ exhibited dose‐independent exposure behaviors with t_1/2 over 8.0 h and oral bioavailability of 0.25–0.29%. A total of seven metabolites were characterized, including two pairs of epimers, 20(R)‐notoginsenoside R₂/20(S)‐notoginsenoside R₂ and 20(R)‐ginsenoside Rh₁/20(S)‐ginsenoside Rh₁, with the 20(R) form of saponins identified for the first time in rat plasma. Five deglycometabolites were quantitatively determined, among which 20(S)‐notoginsenoside R₂, ginsenoside Rg₁, ginsenoside F₁ and protopanaxatriol displayed relatively high exploration, which may partly explain the pharmacodynamic diversity of ginsenosides after oral dose.     

Efficient method for large-scale preparation of two components H and I of Sg-6 saponins from whole seeds of wild soybean (Glycine soja Sieb. and Zucc.)

New saponin components, Sg-6 saponins, have been recently reported from the seeds of wild soybean (Glycine soja) which may have specific health benefits. To evaluate the possible health benefits, a large amount of Sg-6 saponins are needed, but general group A acetyl saponins and new Sg-6 saponins are eluted in overlapping peaks by ordinal preparative high-performance liquid chromatography and/or open column methods. A new method is proposed in this report. This method includes (1) deacetylation of group A acetyl saponins in alkali condition with KOH, (2) precipitation of Sg-6 saponins in acid condition with HCl, (3) recovery of Sg-6 saponins with aqueous methanol from the precipitate, and (4) elution of Sg-6 saponins by preparative reverse-phase open column. With this method, from 450?g of wild soybean whole seed powder, about 1?g of Sg-6 saponins (mixture of six components) was clearly separated from other saponins with 61% recovery.     

Synthetic and spectroscopic characterization of Rh(I)-( S )-amino acid complexes with diphosphine and triphosphine ligands

Reaction of [Rh(η⁴-cod)(S)-amino-acidato] ((S)-amino acidate?=?(S)-O₂C-CHR-NH₂; cod?=?cycloocta-1,5-diene) with 1,2-bis(diphenylphosphino)ethane (dppe) affords the ionic [Rh(dppe)₂]{(S)-O₂C-CHR-NH₂} (R?=?Me, I; Ph, II) complexes. Reactions with 1,3-bis(diphenylphosphino)propane (dppp) or 2,2,2-tris(diphenylphosphinomethyl)ethane (triphos) give the neutral [Rh(dppp){(S)-O₂C-CHR-NH₂}] (R?=?Me, III; Ph, IV) or [Rh(η²-triphos){(S)-O₂C-CHR-NH₂}] (R?=?Me, V; Ph, VI) complexes. The complexes are characterized by elemental analysis, UV–Vis-, IR-, ¹H/³¹P{¹H} NMR- and mass-spectroscopy. Two molecules of dppe coordinate to the Rh(I) symmetrically by replacing both cod and (S)-amino acidate to give I–II. Only one molecule of dppp (or triphos) coordinate to the Rh(I) asymmetrically by replacing only cod to give III–VI. Two diastereomeric Rh(I)-complexes are present in V and VI. The results further suggest that the ligands are arranged in a distorted square planar geometry around the Rh(I) centre. The use of triphos instead of dppe or dppp yields the same coordination sphere.     

Microbial carbonylation and hydroxylation of 20(R)-panaxadiol by Aspergillus niger

20(R)-panaxadiol (PD) was metabolised by the fungus Aspergillus niger AS 3.3926 to its C-3 carbonylated metabolite and five other hydroxylated metabolites (1–6). Their structures were elucidated as 3-oxo-20(R)-panaxadiol (1), 3-oxo-7β-hydroxyl- 20(R)-panaxadiol (2), 3-oxo-7β,23α-dihydroxyl-20(R)-panaxadiol (3), 3,12-dioxo- 7β,23β-dihydroxyl-20(R)-panaxadiol (4), 3-oxo-1α,7β-dihydroxyl-20(R)-panaxadiol (5) and 3-oxo-7β,15β-dihydroxyl-20(R)-panaxadiol (6) by spectroscopic analysis. Among them, compounds 2–6 were new compounds. Pharmacological studies revealed that compound 6 exhibited significant anti-hepatic fibrosis activity.     

Y型分子筛固载(1S,2S)-DPEN-Ru(TPP)2催化苯乙酮不对称加氢

采用自由配体法将(1S,2S)-DPEN(1,2-diphenyl-1,2-ethylene-diamine)-Ru(TPP)2(TPP=三苯基膦,triphenylphosphine)配合物封装于NaY沸石分子筛超笼中,制备了(1S,2S)-DPEN-Ru(TPP)2/Y主客体材料(1S,2S)-DPEN=1,2-二苯基-1,2-乙二胺).采用等离子体发射光谱ICP、粉末X射线衍射(XRD)、紫外光谱(UV-Vis)、氮吸附等物理化学手段对所制备材料进行了表征.结果表明,(1S,2S)-DPEN-Ru(TPP)2配合物封装于Y型分子筛超笼中保持了原有的物理化学性能;作为苯乙酮不对称加氢催化剂,在优化条件下,苯乙酮的转化率可达100%,(R)-苯乙醇的对映体过量值(ee值)可达61.0%.该催化剂具有良好的稳定性和重复使用性.     

Enantioselective Synthesis of the Natural Product (S)‐Rugulactone

A simple and efficient enantioselective synthesis of (6S)‐5,6‐dihydro‐6‐[(2E)‐4‐oxo‐6‐phenylhex‐2‐en‐1‐yl]‐2H‐pyran‐2‐one (=(S)‐rugulactone) has been accomplished. The synthesis started from commercially available propane‐1,3‐diol and ethyl 3‐phenylpropanoate and involve the Horner? Wadsworth? Emmons (HWE) and Still's modified HWE olefinations, and Sharpless asymmetric epoxidation.     

Comparative study on chemical components and anti‐inflammatory effects of Panax notoginseng flower extracted by water and methanol

Methanol and water are commonly used solvents for chemical analysis and traditional decoction, respectively. In the present study, a high‐performance liquid chromatography with ultraviolet detection method was developed to quantify 11 saponins in Panax notoginseng flower extracted by aqueous solution and methanol, and chemical components and anti‐inflammatory effects of these two extracts were compared. The separation of 11 saponins, including notoginsenoside Fc and ginsenoside Rc, was well achieved on a Zorbax SB C18 column. This developed method provides an adequate linearity (r ² > 0.999), repeatability (RSD < 4.26%), inter‐ and intraday variations (RSD < 3.20%) with recovery (94.7–104.1%) of 11 saponins concerned. Our data indicated that ginsenoside biotransformation in PNF was found, when water was used as the extraction solvent, but not methanol. Specifically, the major components of Panax notoginseng flower, ginsenosides Rb1, Rc, Rb2, Rb3, and Rd, can be near completely transformed to the minor components, gypenoside XVII, notoginsenoside Fe, ginsenoside Rd2, notoginsenoside Fd, and ginsenoside F2, respectively. Total protein isolated from Panax notoginseng flower is responsible for this ginsenoside biotransformation. Additionally, methanol extract exerted the stronger anti‐inflammatory effects than water extract in lipopolysaccharide‐induced RAW264.7 cells. This difference in anti‐inflammatory action might be attributed to their chemical difference of saponins.     

Simultaneous quantification of 10 saponins in Chinese Shizhu Panax by UPLC-ESI-MS

A simple and rapid method was established and validated for the simultaneous quantification of 10 saponins, namely ginsenosides-Rb₁, Rb₂, Rb₃, Rc, Rd, Rg₁, Rg₂, Re, Rf and Notoginsenside R₁, in Chinese Shizhu Panax by ultra performance liquid chromatography coupled with an electrospray mass spectrometry (UPLC-ESI-MS). In addition, the contents of the analytes in different parts of Chinese Shizhu Panax were also analysed. The results showed that the concentration of saponins had a reference to the different parts of Chinese Shizhu Panax. The established method could be used as a new analytical approach for assessment of the quantity of Chinese Shizhu Panax.     

Synthèse partielle de la (20S)-ψ-vincamine et de la (20S)-épi-16ψ-vincamine

Partial Synthesis of (20S)-ψ-Vincamine and (20S)-epi-16ψVincamine An attempt of classification of the indole alkaloids is presented; (20S)-ψ-vincamine. (20S)-16-épi-ψ-vincamine and (20S)-ψ-apo-vincamine have been prepared from catharanthine by partial synthesis.     

Recycling Chiral Organocatalyst （4S）-Phenoxy-（S）-proline for Direct Asymmetric Aldol Reaction in Ionic Liquid （bmim）PF6

Room temperature ionic liquid (bmim)PF6 was evaluated for recycling an organocatalyst (4S)-phenoxy-(S)-proline for direct asymmetric aldol reactions. The desired aldol products were obtained with good yields up to 93.2% and enantioselectivities up to 88.5%, and isolation of the products by simple extraction allowed recycling the ionic liquid containing the immobilized catalyst in subsequent reactions without significant decrease of yields and enantioselectivities.     

Biocatalytic desymmetrization of 3-substituted glutaronitriles by nitrilases. A convenient chemoenzymatic access to optically active (S)-Pregabalin and (R)-Baclofen

<正>1 General procedure for the preparation of 3-substituted glutaronitriles To a 100 mL flask containing aldehyde(30 mmol) and cyanoacetic acid(10.20 g, 120 mmol) was added 4-methylpiperidine(0.4 mL) and 23 mL N-methylmorpholine. The reaction mixture was warmed to mild reflux for 24 h and then cooled to room temperature and concentrated on a rotary evaporator. The resulting mixture was dissolved in 100     

改性松香键合二氧化硅高效液相色谱固定相的制备及其对三七总皂苷的分离

三七中发挥药效的主要成分为三七皂苷R1、人参皂苷Rg1、人参皂苷Re、人参皂苷Rb1和人参皂苷Rd,用于贫血、冠心病、高血压、脑卒中后遗症等疾病的治疗,但其化学成分多且难分离.将氢化松香丙烯酸羟乙酯(HRHA)通过巯基-烯点击化学反应键合到烷基化硅胶表面,制备出一种新型的改性松香键合二氧化硅高效液相色谱固定相(SiO2...